TrueBlue (TBI) Cash & Equivalents (2009 - 2026)

TrueBlue (TBI) has 18 years of Cash & Equivalents data on file, last reported at $24.1 million in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $24.1 million, up 4.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $24.1 million (up 4.65% YoY), and the FY2025 annual result was $24.5 million, up 8.76% from the prior year.
• Cash & Equivalents declined to $24.1 million in Q1 2026 per TBI's latest filing, from $24.5 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $72.1 million in Q4 2022 and troughed at $14.5 million in Q3 2024.
• A 5-year average of $35.5 million and a median of $32.4 million in 2022 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2023 and 2024: Cash & Equivalents surged 53.1% in 2023, then plunged 69.21% in 2024.
• A 5-year view of Cash & Equivalents shows it stood at $72.1 million in 2022, then declined by 14.11% to $61.9 million in 2023, then tumbled by 63.58% to $22.5 million in 2024, then rose by 8.76% to $24.5 million in 2025, then slipped by 1.54% to $24.1 million in 2026.
• Business Quant data shows TBI's Cash & Equivalents at $24.1 million in Q1 2026, $24.5 million in Q4 2025, and $19.9 million in Q3 2025.